FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products

The FDA issued warning letters to two companies this month, alleging FD&C Act violations stemming from marketing new drugs without approval. Companies marketing CBD products should be careful not to market OTC drugs containing CBD.

The post FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products appeared first on Cannabis Industry Journal.

CA Health and Safety Warning Laws Have Changed: Are You In Compliance?

A new California Proposition 65 mandate took effect on January 3, requiring health warning labels for all cannabis products sold in the state. Failure to comply with the requirements can and will result in enforcement against cannabis producers and sellers, resulting in hefty penalties.

The post CA Health and Safety Warning Laws Have Changed: Are You In Compliance? appeared first on Cannabis Industry Journal.